Life Science & Biotech

Biomet investing $26M to expand, create nearly 280 jobs

August 13, 2010
 IBJ Staff
Orthopedics giant Biomet Inc. plans to invest $26 million to grow operations in its hometown of Warsaw, adding 278 jobs by the end of 2012.
More

Indiana universities offer cash incentives for technology transfer

August 7, 2010
 IBJ Staff
The Indiana Clinical and Translational Sciences Institute awarded $750,000 to 10 teams of researchers.
More

Dow Agro boosts sales, profit in second quarter

August 3, 2010
 IBJ Staff and Bloomberg News
Indianapolis-based Dow AgroSciences improved sales and profit in its second quarter thanks to higher volumes and lower costs, the company said Tuesday morning.
More

Indiana life sciences companies capture more venture capital money in first half of 2010

July 31, 2010
 IBJ Staff
Venture dollars for Hoosier companies are still few, but the flow of deals is picking up.
More

Lilly's second-quarter profits surge 16 percent

July 22, 2010
J.K. Wall
Indianapolis-based drugmaker Eli Lilly and Co. recorded profits of $1.3 billion, or $1.22 per share, during the three months ended June 30, even after paying $27 million in severance to laid off employees.
More

New rules raise stakes for Lilly drug

July 21, 2010
J.K. Wall
Drugmakers testing experimental Alzheimer’s medicines—including Eli Lilly and Co.—got good news last week when the National Institute on Aging and the Alzheimer’s Association proposed new guidelines to make earlier diagnoses of the disease.
More

Lilly's Lechleiter: No change in plans

July 7, 2010
J.K. Wall
The global financial press keeps asking John Lechleiter for his end-game strategy to survive Eli Lilly and Co.'s nightmarish patent challenges. And, like a broken record, the Lilly CEO keeps giving the same answer: pipeline, pipeline, pipeline—no mega-merger.
More

Marcadia enlists Lilly to help develop new diabetes drug

June 28, 2010
J.K. Wall
The two companies will jointly develop a short-acting glucagon drug, which they hope proves more convenient than Lilly’s current Glucagon for patients with severe hypoglycemia.
More

Q&A

June 23, 2010
J.K. Wall
David Stocum is the director of the Center for Regenerative Biology and Medicine at the IUPUI School of Science. He and his team are studying how amphibians regenerate parts of their bodies to see if there are ways to induce humans to regenerate tissue that is lost or damaged. The center has about 20 researchers and funding of about $14 million to fuel its quest.
More

Indiana's biggest private companies majored in the basics in 2009Restricted Content

June 19, 2010
Martha P. Allan
Health care, plastics, other fundamental consumer needs kept some companies on upswings.
More

Promising ethanol yeast nears market launchRestricted Content

June 19, 2010
Chris O'Malley
A firm that may have developed a breakthrough yeast for ethanol production has landed new investment and high-octane board members. Two-year-old Xylogenics Inc. also says it plans to license its first bioengineered yeast later this year.
More

AIT Labs moving headquarters, adding 160 jobs

June 17, 2010
Scott Olson
The Indianapolis-based forensics, clinical and pharmaceutical testing firm, led by CEO Michael Evans, plans to invest $74 million to acquire and equip an existing 90,000-square-foot building in Woodland Corporate Park near West 79th Street and Interstate 465.
More

UPDATE: Commission approves City Market funding

June 16, 2010
Scott Olson
The Metropolitan Development Commission voted Wednesday afternoon to release nearly $4 million to improve the historic building in downtown Indianapolis.
More

Indiana Seed Fund nearing end of $6 million stashRestricted Content

June 5, 2010
Chris O'Malley
Having invested in 10 companies since 2005 and with its $6 million pot of money running low, the Indiana Seed Fund is nearing a crossroads.
More

OrthoWorx initiative names executive director

June 3, 2010
 IBJ Staff
Not-for-profit launched last year by BioCrossroads and Indiana's orthopedic companies names Zimmer Inc. executive Brad Bishop to lead the initiative.
More

Cancer researcher battling Semafore in courtRestricted Content

May 29, 2010
Chris O'Malley
Former collaborator alleges firm breached its agreement with him and refused to pay royalty income.
More

Biopharma fueling boom in refrigerated warehousing

May 29, 2010
Chris O'Malley
In the past few years, a handful of cold storage facilities have sprouted locally by playing to Indianapolis' strengths in warehousing and life sciences.
More

Indianapolis startup attacks Alzheimer's diseaseRestricted Content

May 29, 2010
Norm Heikens
AgeneBio Inc. this month landed a $300,000 investment from the Indiana Seed Fund to fund operations, bolster its intellectual property, and begin learning how to make a drug into a once-a-day pill.
More

Bioanalytical Systems reports loss in second quarter

May 17, 2010
 IBJ Staff
Bioanalytical Systems Inc. narrowed its losses in the second fiscal quarter despite a 2 percent drop in revenue, the West Lafayette-based contract research firm said late last week.
More

Bioanalytical Systems names new chief executive

May 14, 2010
 IBJ Staff
West Lafayette-based Bioanalytical Systems Inc. has promoted Anthony S. Chilton to CEO following the retirement of top executive Richard M. Shepperd earlier this year.
More

TAYLOR: Reform will drive demand for health care facilities

May 8, 2010
Deeni Taylor
There has been a noticeable uptick in the level of health care real estate development activity this year.
More

Indiana's growth in life sciences jobs beats national average

May 8, 2010
 IBJ Staff
Bloomington led the nation as the No. 1 small city in medical devices and equipment.
More

Dow AgroSciences' profit rises despite lower revenue

April 28, 2010
 IBJ Staff and Associated Press
The Indianapolis unit of Dow Chemical sees quarterly profit rise 6 percent, to $384 million, despite an 8-percent dip in revenue. The parent company reports strongest quarterly results in more than a year.
More

Chao exit hurts drug development industry

April 28, 2010
J.K. Wall
Purdue University’s decision to close the Chao Center in West Lafayette is a setback for Indiana’s effort to grow a vibrant contract drug manufacturing sector. But it’s just the latest in a series of unexpected changes—not all for the worse—since Indianapolis-based BioCrossroads launched a contract drug manufacturing initiative in late 2007.
More

Judge rejects Guidant's defibrillator plea deal

April 27, 2010
Bloomberg News
A federal judge has rejected Guidant Corp.'s guilty plea to charges it hid defects in heart defibrillators, after some doctors and patients complained about the $296 million deal.
More
Page  << 11 12 13 14 15 16 17 18 19 20 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. These liberals are out of control. They want to drive our economy into the ground and double and triple our electric bills. Sierra Club, stay out of Indy!

  2. These activist liberal judges have gotten out of control. Thankfully we have a sensible supreme court that overturns their absurd rulings!

  3. Maybe they shouldn't be throwing money at the IRL or whatever they call it now. Probably should save that money for actual operations.

  4. For you central Indiana folks that don't know what a good pizza is, Aurelio's will take care of that. There are some good pizza places in central Indiana but nothing like this!!!

  5. I am troubled with this whole string of comments as I am not sure anyone pointed out that many of the "high paying" positions have been eliminated identified by asterisks as of fiscal year 2012. That indicates to me that the hospitals are making responsible yet difficult decisions and eliminating heavy paying positions. To make this more problematic, we have created a society of "entitlement" where individuals believe they should receive free services at no cost to them. I have yet to get a house repair done at no cost nor have I taken my car that is out of warranty for repair for free repair expecting the government to pay for it even though it is the second largest investment one makes in their life besides purchasing a home. Yet, we continue to hear verbal and aggressive abuse from the consumer who expects free services and have to reward them as a result of HCAHPS surveys which we have no influence over as it is 3rd party required by CMS. Peel the onion and get to the root of the problem...you will find that society has created the problem and our current political landscape and not the people who were fortunate to lead healthcare in the right direction before becoming distorted. As a side note, I had a friend sit in an ED in Canada for nearly two days prior to being evaluated and then finally...3 months later got a CT of the head. You pay for what you get...

ADVERTISEMENT